Press Releases

GlobeNewswire, Inc.

BARCELONA, Spain, Aug. 30, 2026 (GLOBE NEWSWIRE) -- On August 28, the 2026 VALORANT Champions Tour (VCT) EMEA Finals officially kicked off in Barcelona.

EIN Presswire

Collaboration brings practitioner experience into focus through a regional study on AI adoption, leadership and the changing nature of legal work MONHEIM, GERMANY, October 1, 2026 /⁨EINPresswire.com⁩/ -- TRANSFORMING.LEGAL (TFL), the international...

GlobeNewswire, Inc.

ENCINO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a provider of AI-enabled solutions and services powering OEMs, dealerships and financial institutions to sell, finance and lease assets, today announced a...

GlobeNewswire, Inc.

ATLANTA and LONDON, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Michigan-based K&R International Services (K&R) is using...

GlobeNewswire, Inc.

LAS VEGAS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- TrustWeek 2026—OneTrust, the AI-Ready Governance Platform™, today announced its latest innovations enabling governance programs across privacy, consent, risk, data, and AI to move at the speed of...

GlobeNewswire, Inc.

Milestone follows years of extensive operational diligence, comprehensive validation, and testing across high-volume commercial kitchens.

GlobeNewswire, Inc.

St. Louis, MO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Global law firm Norton Rose Fulbright today announced the appointment of construction and development lawyer Luke Maher as Partner-in-Charge of its St. Louis office.

GlobeNewswire, Inc.

Fiscal Q4 2026 Highlights: Delivered Fiscal Q4 2026 Net Sales of $1.2B, Up 3% Compared to the Prior Year Delivered Fiscal Q4 2026 Diluted EPS of $5.63, Up 56% Compared to the Prior Year; Adjusted Diluted EPS of $5.77, Up 11% Compared to the Prior...

GlobeNewswire, Inc.

TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The CUF-UCC Ukraine Humanitarian Appeal’s Preparing for winter fundraising initiative is receiving a $1 million matching commitment from the Myhal Family Foundation, giving Canadians an opportunity to...

GlobeNewswire, Inc.

IRVINE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned compute systems, critical infrastructure and resilient enterprise...

Government of Slovenia

SLOVENIA, August 14 - The project will facilitate the establishment of an integrated national research infrastructure on genomics providing high-throughput sequencing, genome analysis, as well as safe long-term storage and reuse of data for...

EIN Presswire

European Falcon Farms Expand Presence at Saudi Auction as Investor Interest Grows RIYADH, SAUDI ARABIA, August 10, 2026 /⁨EINPresswire.com⁩/ -- European falcon breeding farms are expanding their participation in Saudi Arabia’s International Falcon...

GlobeNewswire, Inc.

Durham, N.C., Aug. 29, 2026 (GLOBE NEWSWIRE) -- Phase 2 GenePHIT trial successfully randomized and completed enrollment of one of the largest gene therapy trials conducted in heart failure to date, with more than 170 participants randomized across...

GlobeNewswire, Inc.

Additional Results from ACACIA-HCM Demonstrate Improvements in Cardiac Structure and Diastolic Function in Patients with Non-Obstructive HCM New Analysis of MAPLE-HCM Finds Aficamten Outperformed Metoprolol Across Pre-Trial Treatment Groups in...

GlobeNewswire, Inc.

Primary composite endpoint met: 61% of patients achieved visual and pathological response across all treated lesions.

GlobeNewswire, Inc.

DUBLIN and BRIDGEWATER, N.J., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today highlighted a new post hoc analysis from the landmark...

GlobeNewswire, Inc.

NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced it will host a KOL Investor Event on...

GlobeNewswire, Inc.

ACACIA-HCM is the First Phase 3 Clinical Trial to Successfully Demonstrate Statistically Significant Improvements Across Both Patient-Reported and Physician-Assessed Endpoints in Non-Obstructive HCM Supplemental New Drug Application to be...

GlobeNewswire, Inc.

WUHU, China, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The appeal of Crossover has always been its limitless potential.

GlobeNewswire, Inc.

COSTA MESA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Phocas, a leading business intelligence (BI) and financial planning and analysis (FP&A) platform for distributors in the middle-market today announced the winners of its inaugural Phocas...